Work

25750 Tapinarof cream 1% once daily for plaque psoriasis: Secondary efficacy outcomes from two pivotal phase 3 trials

Year: 2021

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2021.06.300

Authors: Linda Stein Gold, Andrew Blauvelt, April Armstrong, Seemal R. Desai, Howard Sofen, Lawrence J. Green, Stephen K. Tyring, Laura K. Ferris, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli

Institutions: Henry Ford Health, Oregon Medical Research Center, University of Southern California, The University of Texas Southwestern Medical Center, University of California, Los Angeles, George Washington University, The University of Texas Health Science Center at Houston, UPMC Health System, University of Pittsburgh Medical Center

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3195864296

FWCI: 0.224

Cites:

Cited by: 3

Related to: 10